ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy